Table 3.

Distribution of HPV genotypes according to cytology abnormalities

	NILM	AGC	ASC-H	ASC-US	LSIL	HSIL
	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)	No. (%)
HR-HPV
HPV16	379 (11.1)	2 (40.0)	6 (40.0)	37 (15.7)	34 (19.8)	24 (40.7)
HPV18	152 (4.4)	0 (0.0)	0 (0.0)	13 (5.5)	7 (4.1)	8 (13.6)
HPV31	141 (4.1)	0 (0.0)	0 (0.0)	12 (5.1)	4 (2.3)	5 (8.5)
HPV33	198 (5.8)	1 (20.0)	4 (26.7)	11 (4.7)	9 (5.2)	7 (11.9)
HPV35	60 (1.8)	1 (20.0)	0 (0.0)	1 (0.4)	2 (1.2)	2 (3.4)
HPV39	274 (8.0)	0 (0.0)	1 (6.7)	1 4(5.9)	7 (4.1)	1 (1.7)
HPV45	52 (1.5)	1 (20.0)	1 (6.7)	5 (2.1)	0 (0.0)	1 (1.7)
HPV51	306 (8.9)	0 (0.0)	0 (0.0)	23 (9.8)	25 (14.5)	1 (1.7)
HPV52	854 (24.9)	1 (20.0)	5 (33.3)	65 (27.5)	39 (22.7)	7 (11.9)
HPV53	313 (9.1)	0 (0.0)	2 (13.3)	21 (8.9)	22 (12.8)	0 (0.0)
HPV56	163 (4.8)	0 (0.0)	0 (0.0)	19 (8.1)	22 (12.8)	0 (0.0)
HPV58	463 (13.5)	2 (40.0)	4 (26.7)	45 (19.1)	32 (18.6)	10 (17.0)
HPV59	143 (4.2)	0 (0.0)	0 (0.0)	12 (5.1)	10 (5.8)	0 (0.0)
HPV66	230 (6.7)	1 (20.0)	1 (6.7)	14 (5.9)	16 (9.3)	0 (0.0)
HPV68	225 (6.6)	1 (20.0)	0 (0.0)	17 (7.2)	7 (4.1)	0 (0.0)
HPV73	18 (1.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)	0 (0.0)
HPV82	21 (1.1)	0 (0.0)	0 (0.0)	1 (0.8)	1 (1.2)	0 (0.0)
HPV83	6 (0.3)	0 (0.0)	0 (0.0)	2 (1.7)	0 (0.0)	0 (0.0)
LR-HPV
HPV6	118 (3.5)	0 (0.0)	1 (6.7)	11 (4.7)	6 (3.5)	1 (1.7)
HPV11	63 (1.8)	0 (0.0)	0 (0.0)	4 (1.7)	6 (3.5)	0 (0.0)
HPV42	222 (6.5)	0 (0.0)	0 (0.0)	18 (7.6)	15 (8.7)	1 (1.7)
HPV43	95 (2.8)	0 (0.0)	0 (0.0)	11 (4.7)	3 (1.7)	0 (0.0)
HPV44	162 (4.7)	0 (0.0)	0 (0 .0)	5 (2.1)	3 (1.7)	1 (1.7)
HPV81	124 (6.5)	0 (0.0)	0 (0.0)	6 (5.0)	5 (6.0)	1 (4.0)
CP8304	136 (8.9)	0 (0.0)	0 (0.0)	10 (8.6)	5 (5.7)	1 (3.0)